Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Sugiyama

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[Second-line treatment using novel chemotherapeutic and biologic agents]Toru Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 11, 2015
[Insulinoma]Toru Sugiyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2005
[Ovarian cancer]Toru Sugiyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2005
[Second-line chemotherapy for recurrent ovarian cancer]Toru Sugiyama
International Journal of Clinical Oncology|July 20, 2006
Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?Toru Sugiyama
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|March 24, 2009
[A case of depression with avoidance tendency showing successful reinstatement at work]Toru Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Endothelin-1 and arteriosclerosis]Toru Sugiyama, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Atrial natriuretic peptide gene]Toru Sugiyama, Yukio Hirata
American Journal of Physiology. Heart and Circulatory Physiology|November 10, 2009
Thiol-metabolizing proteins and endothelial redox state: differential modulation of eNOS and biopterin pathwaysToru Sugiyama, Thomas Michel
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Maintenance therapy in patients with advanced epithelial ovarian cancer-impact of anti-angiogenic molecular targeted agents in progress]Satoshi Takeuchi, Toru Sugiyama
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
[Second-line treatment using novel chemotherapeutic and biologic agents]Toru Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 11, 2015
[Insulinoma]Toru Sugiyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 27, 2005
[Ovarian cancer]Toru Sugiyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 29, 2005
[Second-line chemotherapy for recurrent ovarian cancer]Toru Sugiyama
International Journal of Clinical Oncology|July 20, 2006
Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?Toru Sugiyama
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|March 24, 2009
[A case of depression with avoidance tendency showing successful reinstatement at work]Toru Sugiyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2004
[Endothelin-1 and arteriosclerosis]Toru Sugiyama, Yukio Hirata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[Atrial natriuretic peptide gene]Toru Sugiyama, Yukio Hirata
American Journal of Physiology. Heart and Circulatory Physiology|November 10, 2009
Thiol-metabolizing proteins and endothelial redox state: differential modulation of eNOS and biopterin pathwaysToru Sugiyama, Thomas Michel
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Maintenance therapy in patients with advanced epithelial ovarian cancer-impact of anti-angiogenic molecular targeted agents in progress]Satoshi Takeuchi, Toru Sugiyama
Pageof 24